Amarin Corporation PLC Ending Cash

Ending Cash of AMRN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Ending Cash growth rates and interactive chart.


Highlights and Quick Summary

  • Ending Cash for the quarter ending June 30, 2022 was $8.85 Million (a -96.03% decrease compared to previous quarter)
  • Year-over-year quarterly Ending Cash decreased by -108.5%
  • Annual Ending Cash for 2021 was $223 Million (a 17.02% increase from previous year)
  • Annual Ending Cash for 2020 was $191 Million (a -70.57% decrease from previous year)
  • Annual Ending Cash for 2019 was $648 Million (a 158.65% increase from previous year)
  • Twelve month Ending Cash ending June 30, 2022 was $124 Million (a -17.93% decrease compared to previous quarter)
  • Twelve month trailing Ending Cash decreased by -39.79% year-over-year
Trailing Ending Cash for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
$124 Million $152 Million $223 Million $207 Million
Visit stockrow.com/AMRN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Ending Cash of Amarin Corporation PLC

Most recent Ending Cashof AMRN including historical data for past 10 years.

Interactive Chart of Ending Cash of Amarin Corporation PLC

Amarin Corporation PLC Ending Cash for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $8.85 $223.07
2021 $-3.42 $-104.14 $36.02 $294.91 $223.37
2020 $-20.24 $-6.8 $-115.04 $332.96 $190.88
2019 $-28.62 $453.84 $10.68 $212.59 $648.5
2018 $168.24 $-20.37 $-26.79 $129.65 $250.73
2017 $-5.45 $-6.38 $-10.61 $96.68 $74.24
2016 $-19.31 $45.07 $-8.87 $81.36 $98.25
2015 $-12.02 $-17.07 $-25.15 $161.2 $106.96
2014 $-15.9 $-15.09 $-13.75 $164.28 $119.54
2013 $-34.37 $76.46 $-52.35 $201.78 $191.51
2012 $45.13 $-35.15 $4.43 $245.82 $260.24
2011 $-9.25 $-5.59 $116.6

Business Profile of Amarin Corporation PLC

Sector: Healthcare
Industry: Biotechnology